BSPKOTCPharmaceutical PreparationsFiscal year ends December 31
Bespoke Extracts, Inc.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 12, 2025
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $5.62K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.2395 (−99.79%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Bespoke Extracts, Inc. grew revenue 31.8% to $1.42M over the twelve months to Sep 30, 2025. Free cash flow was -$889.80K.
Revenue
$1.42M
+31.8% vs. a year earlier
Operating income
-$640.30K
TTM Q3 2025
Free cash flow
-$889.80K
FY2024
EPS, diluted
-$0.07
TTM Q3 2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2025
Valuation
- Market cap
- $5.62K
- P/E ratio
- –
- Price to sales
- 0.00
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -15818.76%
Fundamentals
- Revenue
- $1.42M
- Net income
- -$730.56K
- EPS, diluted
- -$0.07
- Free cash flow
- -$889.80K
- Book value per share
- -$0.23
- Diluted shares
- 11M
Thirteen years at a glance
Fiscal years 2011 to 2024 and trailing twelve months, USD
Revenue
$1.42M+31.8% YoY
Gross profit
$671.70K+37.9% YoY
Operating income
-$640.30K
Net income
-$730.56K
EPS, diluted
-$0.07
Free cash flow
–
Reported periodTrailing twelve months